Welcome to our dedicated page for LataMed AI SEC filings (Ticker: LMED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on LataMed AI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into LataMed AI's regulatory disclosures and financial reporting.
LataMed AI Corp. is implementing a 5-for-1 forward stock split that became effective at the opening of trading after its corporate action appeared on the FINRA Daily List dated July 14, 2026. Common stock now trades under temporary symbol LMEDD with a “D” suffix expected for approximately twenty business days before reverting to LMED.
The split is tied to a mandatory share exchange and a new CUSIP number 21116R404, with the prior CUSIP 21116R305 suspended upon effectiveness. Shares held in brokerage or book-entry form are expected to adjust automatically, while holders of physical certificates will receive the appropriate number of post-split shares when they submit certificates through the transfer agent.
The company continues to focus on expanding its telemedicine platform and commercializing its CardioAI, PulmoAI, and NeuroAI healthcare AI solutions, initially targeting Latin American markets.
LATAMED AI Corp. amended its Nevada charter to significantly expand its capital structure and split its stock. Authorized common stock increased from 700,000,000 shares to 3,500,000,000 shares, par value $0.0001 per share, and authorized preferred stock increased from 300,000,000 shares to 1,500,000,000 shares, par value $0.0001 per share. The change also effected a five-for-one forward split of issued and outstanding common shares, reclassifying each one share into five shares of common stock.